Shifting Goalposts For Vaccine Cos As Lambda Variant Rears Head

Multiple Vaccines Show Delta Efficacy

Studies point to Johnson & Johnson, Pfizer and Bharat Biotech’s vaccines neutralizing the Delta variant of SARS-CoV-2, even if efficacy is lower compared to the original strain. This follows positive news from other vaccine companies but will the Lambda variant cause a setback?

Coronavirus Variant Emerging/Mutated SARS-CoV-2
The Changing Colors Of SARS-CoV-2 Present A Challenge To Vaccine Makers • Source: Alamy

More from R&D

More from Scrip